Exam Preview for 38949: Ototoxicity Monitoring Programs: Addressing

Ototoxicity Monitoring Programs: Addressing Existing Barriers

Please note: exam questions are subject to change.

1. Which of the following is as symptom caused by ototoxicity? Sensation of fullness in the ears Tinnitus Hyperacusis All of the above
2. Which of the following are classified under drug class: aminoglycosides? Vancomycin Gentamycin and neomycin Tylenol None of the above
3. The American Academy of Audiology and the American Speech-Language & Hearing Association suggest post treatment monitoring should be done within how many months of treatment cessation? 3 4 6 8
4. If baseline is missed prior to administration of the drug, testing must be completed within ____ of the initial dose. 24 hours 48 hours 1 week 6 weeks
5. Which of the following is considered to be a barrier in the effective implementation of a consistent protocol for ototoxicity monitoring? Patient access and education Collaboration and communication between disciplines Audiology inclusion None of the above